SEEL logo

Seelos Therapeutics (SEEL) Total Assets

Annual Total Assets

$5.42 M
-$17.33 M-76.18%

December 31, 2023

Summary

Performance

1-Year Change

-76.18%

3-Year Change

-69.03%

5-Year Change

+44.1%

15-Year Change

-19.21%

SEEL Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

6.79%
SEEL annual total assets is higher than 6.79% of companies in Healthcare sector

High & Low

All-time High

$83.50 M
SEEL annual total assets is currently -93.51% below its historical high of $83.50 million

3-Year Low

$5.42 M
SEEL annual total assets is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SEEL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
SEEL next annual earnings announcement has not yet been scheduled

OtherSEELbalance sheetmetrics:

Annual Current Assets

$5.40 M
SEEL annual total current assets is $5.40 million

Annual Non Current Assets

$15.00 K
SEEL annual long term assets is $15.00 thousand

Annual Total Liabilities

$38.93 M
SEEL annual total liabilities is $38.93 million

Annual Current Liabilities

$38.93 M
SEEL annual total current liabilities is $38.93 million

Quarterly Total Assets

$2.38 M
-$1.23 M-34.08%

June 30, 2024

Summary

Performance

3-Month Change

-34.08%

1-Year Change

-61.71%

3-Year Change

-89.53%

5-Year Change

-76.84%

SEEL Quarterly Total Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

2.27%
SEEL quarterly total assets is higher than 2.27% of companies in Healthcare sector

High & Low

All-time High

$90.31 M
SEEL quarterly total assets is currently -97.36% below its historical high of $90.31 million

3-Year Low

$2.38 M
SEEL quarterly total assets is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
SEEL previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
SEEL next earnings announcement has not yet been scheduled

OtherSEELbalance sheetmetrics:

Quarterly Current Assets

$2.33 M
SEEL quarterly total current assets is $2.33 million

Quarterly Non Current Assets

$47.00 K
SEEL quarterly long term assets is $47.00 thousand

Quarterly Total Liabilities

$30.51 M
SEEL quarterly total liabilities is $30.51 million

Quarterly Current Liabilities

$30.51 M
SEEL quarterly total current liabilities is $30.51 million

Total Assets Formula

Total Assets = Current Assets + Non-Current Assets

Annual Total Assets

$5.42 M
SEEL annual total assets is $5.42 million

Annual Non Current Assets

$15.00 K
SEEL annual long term assets is $15.00 thousand

Annual Current Assets

$5.40 M
SEEL annual total current assets is $5.40 million

SEEL Total Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-76.2%-61.7%
3 y3 years-69.0%-89.5%
5 y5 years+44.1%-76.8%

SEEL Total Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-93.5%at low-97.2%at low
5 y5-year-93.5%at low-97.4%at low
alltimeall time-93.5%+132.2%-97.4%at low

Seelos Therapeutics Total Assets History

DateAnnualQuarterly
Jun 2024
-
$2.38 M(-34.1%)
Mar 2024
-
$3.61 M(-33.3%)
Dec 2023
$5.42 M(-76.2%)
$5.42 M(-12.9%)
Sep 2023
-
$6.22 M(-47.7%)
Jun 2023
-
$11.89 M(-49.7%)
Mar 2023
-
$23.64 M(+3.9%)
Dec 2022
$22.75 M(-72.8%)
$22.75 M(-43.8%)
Sep 2022
-
$40.51 M(-23.1%)
Jun 2022
-
$52.67 M(-25.5%)
Mar 2022
-
$70.69 M(-15.3%)
Dec 2021
$83.50 M(+377.3%)
$83.50 M(+3.2%)
Sep 2021
-
$80.95 M(-10.4%)
Jun 2021
-
$90.31 M(+118.3%)
Mar 2021
-
$41.37 M(+136.5%)
Dec 2020
$17.49 M(+57.7%)
$17.49 M(+77.1%)
Sep 2020
-
$9.88 M(+27.3%)
Jun 2020
-
$7.76 M(-45.2%)
Mar 2020
-
$14.17 M(+27.7%)
Dec 2019
$11.10 M(+195.1%)
$11.10 M(-31.6%)
Sep 2019
-
$16.21 M(+57.7%)
Jun 2019
-
$10.28 M(-16.7%)
Mar 2019
-
$12.34 M(+228.3%)
Dec 2018
$3.76 M(-43.9%)
$3.76 M(-32.4%)
Sep 2018
-
$5.56 M(-23.0%)
Jun 2018
-
$7.22 M(+20.0%)
Mar 2018
-
$6.02 M(-10.2%)
Dec 2017
$6.71 M(+42.7%)
$6.71 M(-24.0%)
Sep 2017
-
$8.82 M(+0.1%)
Jun 2017
-
$8.81 M(+64.7%)
Mar 2017
-
$5.35 M(+13.9%)
Dec 2016
$4.70 M(-39.6%)
$4.70 M(-44.1%)
Sep 2016
-
$8.41 M(+36.4%)
Jun 2016
-
$6.17 M(-40.9%)
Mar 2016
-
$10.43 M(+34.1%)
Dec 2015
$7.78 M(-47.5%)
$7.78 M(-18.9%)
Sep 2015
-
$9.60 M(-15.7%)
Jun 2015
-
$11.39 M(-42.0%)
Mar 2015
-
$19.64 M(+32.6%)
Dec 2014
$14.81 M(-36.5%)
$14.81 M(-25.2%)
Sep 2014
-
$19.80 M(-2.4%)
Jun 2014
-
$20.29 M(-18.8%)
Mar 2014
-
$24.99 M(+7.2%)
Dec 2013
$23.31 M(-2.4%)
$23.31 M(+4.5%)
Sep 2013
-
$22.30 M(-17.2%)
Jun 2013
-
$26.92 M(+61.9%)
Mar 2013
-
$16.63 M(-30.4%)
Dec 2012
$23.88 M(+43.7%)
$23.88 M(-41.4%)
Sep 2012
-
$40.75 M(+39.6%)
Jun 2012
-
$29.20 M(-8.4%)
Mar 2012
-
$31.88 M(+91.8%)
DateAnnualQuarterly
Dec 2011
$16.62 M(-11.9%)
$16.62 M(+18.9%)
Sep 2011
-
$13.98 M(-0.7%)
Jun 2011
-
$14.08 M(-28.2%)
Mar 2011
-
$19.60 M(+3.9%)
Dec 2010
$18.86 M(-9.9%)
$18.86 M(-12.8%)
Sep 2010
-
$21.63 M(-11.6%)
Jun 2010
-
$24.48 M(+9.8%)
Mar 2010
-
$22.29 M(+6.5%)
Dec 2009
$20.93 M(+144.6%)
$20.93 M(+214.9%)
Sep 2009
-
$6.65 M(-17.4%)
Jun 2009
-
$8.05 M(-12.6%)
Mar 2009
-
$9.21 M(+7.7%)
Dec 2008
$8.56 M(-19.8%)
$8.56 M(+2.5%)
Sep 2008
-
$8.35 M(-20.5%)
Jun 2008
-
$10.50 M(+11.4%)
Mar 2008
-
$9.43 M(-11.7%)
Dec 2007
$10.67 M(-46.5%)
$10.67 M(-4.6%)
Sep 2007
-
$11.19 M(-14.4%)
Jun 2007
-
$13.07 M(-28.2%)
Mar 2007
-
$18.19 M(-8.7%)
Dec 2006
$19.93 M(+49.5%)
$19.93 M(+40.3%)
Sep 2006
-
$14.21 M(-11.6%)
Jun 2006
-
$16.08 M(-8.2%)
Mar 2006
-
$17.52 M(+31.4%)
Dec 2005
$13.33 M(-34.2%)
$13.33 M(-22.8%)
Sep 2005
-
$17.27 M(+12.5%)
Jun 2005
-
$15.34 M(-0.1%)
Mar 2005
-
$15.35 M(-24.3%)
Dec 2004
$20.27 M(-12.4%)
$20.27 M(+13.8%)
Sep 2004
-
$17.81 M(-22.7%)
Jun 2004
-
$23.03 M(+19.9%)
Mar 2004
-
$19.20 M(-17.0%)
Dec 2003
$23.13 M(+63.6%)
$23.13 M(+14.3%)
Sep 2003
-
$20.24 M(+48.5%)
Jun 2003
-
$13.63 M(+10.6%)
Mar 2003
-
$12.33 M(-12.8%)
Dec 2002
$14.14 M(-48.2%)
$14.14 M(-23.3%)
Sep 2002
-
$18.42 M(-26.5%)
Jun 2002
-
$25.06 M(+18.2%)
Mar 2002
-
$21.21 M(-22.4%)
Dec 2001
$27.31 M(-31.7%)
$27.31 M(-14.4%)
Sep 2001
-
$31.91 M(-6.4%)
Jun 2001
-
$34.11 M(-9.5%)
Mar 2001
-
$37.67 M(-5.8%)
Dec 2000
$39.99 M(+426.2%)
$39.99 M(-4.7%)
Sep 2000
-
$41.97 M(+123.7%)
Jun 2000
-
$18.76 M(+52.2%)
Mar 2000
-
$12.32 M
Dec 1999
$7.60 M(+28.3%)
-
Dec 1998
$5.92 M(+154.0%)
-
Dec 1997
$2.33 M
-

FAQ

  • What is Seelos Therapeutics annual total assets?
  • What is the all time high annual total assets for Seelos Therapeutics?
  • What is Seelos Therapeutics annual total assets year-on-year change?
  • What is Seelos Therapeutics quarterly total assets?
  • What is the all time high quarterly total assets for Seelos Therapeutics?
  • What is Seelos Therapeutics quarterly total assets year-on-year change?

What is Seelos Therapeutics annual total assets?

The current annual total assets of SEEL is $5.42 M

What is the all time high annual total assets for Seelos Therapeutics?

Seelos Therapeutics all-time high annual total assets is $83.50 M

What is Seelos Therapeutics annual total assets year-on-year change?

Over the past year, SEEL annual total assets has changed by -$17.33 M (-76.18%)

What is Seelos Therapeutics quarterly total assets?

The current quarterly total assets of SEEL is $2.38 M

What is the all time high quarterly total assets for Seelos Therapeutics?

Seelos Therapeutics all-time high quarterly total assets is $90.31 M

What is Seelos Therapeutics quarterly total assets year-on-year change?

Over the past year, SEEL quarterly total assets has changed by -$3.84 M (-61.71%)